British Journal of Cancer · 1999 · 23 citations · 27 references
MedicineOncologyPathologyApoptosisNeoplasiaTumor ProgressionApoptosis In CancerBcl-2 Family ProteinsMalignant NeoplasmsPancreatic CancerPancreatic PathologyTumor MarkersBcl-2 Protein ExpressionCorrelationHistological Grade PrognosisImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingP53-mediated Apoptosis
p53 and Bcl-2 are two important factors related to apoptosis and tumorigenesis. In this study, a series of 52 cases of pancreatic carcinoma (PC) were investigated using an immunohistochemical assay to determine whether altered expression of Bcl-2 and p53 has an impact on the progression of this malignancy. Cytoplasmic immunoreactivity for Bcl-2 and nuclear staining of p53 was found in 12 (23.1%) and 32 (63.5%) cases of PC respectively. Furthermore, an inverse correlation between the expression of p53 and Bcl-2 existed in this series (P < 0.01). In a subgroup, the proportion of tumours showing that p53-positive and Bcl-2-negative staining was increased with increasing histological grade and clinical stage (P < 0.05), and moreover, the survival period of those patients whose tumour had this staining was shorter than those with other staining patterns of combined p53 and Bcl-2 (P < 0.05). Therefore, it is concluded that simultaneously aberrant expression of Bcl-2 and p53 may confer PC with more malignant clinicopathological characteristics.
27
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Kristina M. Dameron, Olga V. Volpert, Michael A. Tainsky et al. · Science · 1994 · 1.4K citations
Identification of a p53-dependent negative response element in the bcl-2 gene.
Toshiyuki Miyashita, Masayoshi Harigai, Masahito Hanada et al. · PubMed · 1994 · 747 citations
bcl-2 Protein in Non-Small-Cell Lung Carcinoma
Francesco Pezzella, Helen Turley, M F Tungekar et al. · New England Journal of Medicine · 1993 · 676 citations · Full text